Abstract
Nanoparticles (NPs) are widely applied in nanomedicine and diagnostics based on the interactions between NPs and the basic barrier (biomembrane). Understanding the underlying mechanism of these interactions is important for enhancing their beneficial effects and avoiding potential nanotoxicity. Experimental, mathematical and numerical modeling techniques are involved in this field. This article reviews the state-of-the-art techniques in studies of NP–biomembrane interactions with a focus on each technology's advantages and disadvantages. The aim is to better understand the mechanism of NP–biomembrane interactions and provide significant guidance for various fields, such as nanomedicine and diagnosis.
Papers of special note have been highlighted as: • of interest
References
- 1 . Silver nanoparticles as a safe preservative for use in cosmetics. Nanomed. Nanotechnol. Biol. Med. 6(4), 570–574 (2010).
- 2 Designing novel hybrid materials by one-pot co-condensation: from hydrophobic mesoporous silica nanoparticles to superamphiphobic cotton textiles. ACS Appl. Mater. Interfaces 3(7), 2289–2299 (2011).
- 3 . Functionalized building materials: photocatalytic abatement of NOx by cement pastes blended with TiO2 nanoparticles. Constr. Build. Mater. 36, 820–825 (2012).
- 4 Tunable nanowire patterning using standing surface acoustic waves. ACS Nano 7(4), 3306–3314 (2013).
- 5 . The unique role of nanoparticles in nanomedicine: imaging, drug delivery and therapy. Chem. Soc. Rev. 41(7), 2885–2911 (2012).
- 6 . Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties. ACS Nano 6(1), 736–746 (2011).
- 7 . Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? J. Pharm. Sci. 99(1), 21–50 (2010).
- 8 Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials 31(25), 6574–6581 (2010).
- 9 . Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2(12), 751–760 (2007).
- 10 . Nanoparticle and targeted systems for cancer therapy. Adv. Drug Deliv. Rev. 56, (11), 1649–1659 (2004).
- 11 . pH-induced aggregation of gold nanoparticles for photothermal cancer therapy. J. Am. Chem. Soc. 131(38), 13639–13645 (2009).
- 12 . Gold hybrid nanoparticles for targeted phototherapy and cancer imaging. Nanotechnology 21(10), 105105 (2010).
- 13 . Cytotoxicity of nanoparticles. Small 4(1), 26–49 (2008).
- 14 Wide varieties of cationic nanoparticles induce defects in supported lipid bilayers. Nano Lett. 8(2), 420–424 (2008).
- 15 Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small 5(18), 2067–2076 (2009).
- 16 . Cellular uptake of nanoparticles by membrane penetration: a study combining confocal microscopy with FTIR spectroelectrochemistry. ACS Nano 6(2), 1251–1259 (2012).
- 17 . The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat. Nanotechnol. 6(6), 385–391 (2011).
- 18 Estimating the effective density of engineered nanomaterials for in vitro dosimetry. Nat. Commun. 5, 3514 (2014).
- 19 . Cellular uptake of elastic nanoparticles. Phys. Rev. Lett. 107(9), 098101 (2011).
- 20 . Cell entry of one-dimensional nanomaterials occurs by tip recognition and rotation. Nat. Nanotechnol. 6(11), 714–719 (2011).• Investigates cell entry of 1D nanomaterials using a scanning electron microscopy-based experimental technique and coarse-grained molecular dynamic simulations.
- 21 . Computer simulation of the translocation of nanoparticles with different shapes across a lipid bilayer. Nat. Nanotechnol. 5(8), 579–583 (2010).
- 22 Advances in the understanding of nanomaterial–biomembrane interactions and their mathematical and numerical modeling. Nanomedicine (Lond.) 8(6), 995–1011 (2013).• Illustrates the recent advances in the understanding of nanomaterial–biomembrane interactions based on their numerical modeling.
- 23 Molecular analysis of interactions between dendrimers and asymmetric membranes at different transport stages. Soft Matter 10(1), 139–148 (2014).
- 24 . Deformation and poration of lipid bilayer membranes by cationic nanoparticles. Soft Matter 9(20), 4969–4976 (2013).
- 25 . Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug. Chem. 15(4), 897–900 (2004).
- 26 . Genotoxic and cytotoxic potential of titanium dioxide (TiO2) nanoparticles on fish cells in vitro. Ecotoxicology 17(5), 410–420 (2008).
- 27 Direct observation of lipid bilayer disruption by poly(amidoamine) dendrimers. Chem. Phys. Lipids 132(1), 3–14 (2004).
- 28 . In vitro and intracellular production of peptide-encapsulated fluorescent silver nanoclusters. Angew. Chem. Int. Ed. Engl. 119(12), 2074–2076 (2007).
- 29 . Endosomal leakage and nuclear translocation of multiwalled carbon nanotubes: developing a model for cell uptake. Nano Lett. 9(12), 4370–4375 (2009).
- 30 . On the biomedical promise of cell penetrating peptides: limits versus prospects. J. Pharm. Sci. 97(1), 144–162 (2008).
- 31 . Near-infrared fluorescence microscopy of single-walled carbon nanotubes in phagocytic cells. J. Am. Chem. Soc. 126(48), 15638–15639 (2004).
- 32 . Single-particle tracking of endocytosis and exocytosis of single-walled carbon nanotubes in NIH-3T3 cells. Nano Lett. 8(6), 1577–1585 (2008).
- 33 . Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 21(23), 10644–10654 (2005).
- 34 Uptake mechanism of oppositely charged fluorescent nanoparticles in HeLa cells. Macromol. Biosci. 8(12), 1135–1143 (2008).
- 35 . Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem. Biophys. Res. Commun. 353(1), 26–32 (2007).
- 36 . Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells. J. Am. Chem. Soc. 128(46), 14792–14793 (2006).
- 37 Targeting of porous hybrid silica nanoparticles to cancer cells. ACS Nano 3(1), 197–206 (2008).
- 38 . Effect of surface properties on nanoparticle–cell interactions. Small 6(1), 12–21 (2010).
- 39 . Nano–bio effects: interaction of nanomaterials with cells. Nanoscale 5(9), 3547–3569 (2013).
- 40 . Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. ACS Nano 5(2), 1366–1375 (2011).
- 41 . The effects of aggregation and protein corona on the cellular internalization of iron oxide nanoparticles. Biomaterials 32(35), 9353–9363 (2011).
- 42 Graphene microsheets enter cells through spontaneous membrane penetration at edge asperities and corner sites. Proc. Natl Acad. Sci. USA 110(30), 12295–12300 (2013).
- 43 . Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture. J. Mater. Sci. Mater. Med. 15(4), 493–496 (2004).
- 44 Surface charge dependent nanoparticle disruption and deposition of lipid bilayer assemblies. Langmuir 28(50), 17396–17403 (2012).
- 45 . Atomic force microscopy studies of a floating-bilayer lipid membrane on a Au(111) surface modified with a hydrophilic monolayer. Langmuir 27(17), 10867–10877 (2011).
- 46 Interactions of poly(amidoamine) dendrimers with survanta lung surfactant: the importance of lipid domains. Langmuir 24(19), 11003–11008 (2008).
- 47 . Relevance of biophysical interactions of nanoparticles with a model membrane in predicting cellular uptake: study with TAT peptide-conjugated nanoparticles. Mol. Pharm. 6(5), 1311–1320 (2009).
- 48 . Interaction of nanoparticles with lipid membrane. Nano Lett. 8(3), 941–944 (2008).
- 49 Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjug. Chem. 15(4), 774–782 (2004).
- 50 Interaction of polycationic polymers with supported lipid bilayers and cells: nanoscale hole formation and enhanced membrane permeability. Bioconjug. Chem. 17(3), 728–734 (2006).
- 51 . Synthetic and natural polycationic polymer nanoparticles interact selectively with fluid-phase domains of DMPC lipid bilayers. Langmuir 21(19), 8588–8590 (2005).
- 52 . Interaction of lipid membrane with nanostructured surfaces. Langmuir 25(11), 6287–6299 (2009).
- 53 . Atomic force microscopy of model lipid membranes. Anal. Bioanal. Chem. 405(5), 1445–1461 (2013).
- 54 . Biophysical applications of scanning ion conductance microscopy (SICM). Mod. Phys. Lett. B 26(05), 1130003 (2012).
- 55 . Scanning ion conductance microscopy. Annu. Rev. Anal. Chem. 5(1), 207–228 (2012).
- 56 Respiratory epithelial cytotoxicity and membrane damage (holes) caused by amine-modified nanoparticles. Nanotoxicology 6(1), 94–108 (2012).
- 57 Real-time investigation of acute toxicity of ZnO nanoparticles on human lung epithelia with hopping probe ion conductance microscopy. Chem. Res. Toxicol. 25(2), 297–304 (2011).
- 58 Scanning surface confocal microscopy for simultaneous topographical and fluorescence imaging: application to single virus-like particle entry into a cell. Proc. Natl Acad. Sci. USA 99(25), 16018–16023 (2002).
- 59 Functional interaction between charged nanoparticles and cardiac tissue: a new paradigm for cardiac arrhythmia? Nanomedicine 8(5), 725–737 (2012).
- 60 . Idebenone loaded solid lipid nanoparticles interact with biomembrane models: calorimetric evidence. Mol. Pharm. 9(9), 2534–2541 (2012).• Investigates the interaction of idebenone-loaded solid lipid nanoparticles with multilamellar vesicles using the differential scanning calorimetry method.
- 61 Interactions of phosphorus-containing dendrimers with liposomes. Biochim. Biophys. Acta 1811(3), 221–226 (2011).
- 62 . Hydrophobicity drives the cellular uptake of short cationic peptide ligands. Eur. Biophys. J. 40(6), 727–736 (2011).
- 63 Membrane interaction and perturbation mechanisms induced by two cationic cell penetrating peptides with distinct charge distribution. Biochim. Biophys. Acta 1780(7–8), 948–959 (2008).
- 64 . Giant vesicles: preparations and applications. ChemBioChem 11(7), 848–865 (2010).
- 65 . Choosing membrane mimetics for NMR structural studies of transmembrane proteins. Biochim. Biophys. Acta 1808(8), 1957–1974 (2011).
- 66 . Comparative study of the interaction of fullerenol nanoparticles with eukaryotic and bacterial model membranes using solid-state NMR and FTIR spectroscopy. Eur. Biophys. J. 41(6), 535–544 (2012).
- 67 Cationic carbosilane dendrimers–lipid membrane interactions. Chem. Phys. Lipids 165(4), 401–407 (2012).
- 68 Solid-state NMR reveals the hydrophobic-core location of poly(amidoamine) dendrimers in biomembranes. J. Am. Chem. Soc. 132(23), 8087–8097 (2010).
- 69 Insertion mechanism of cell-penetrating peptides into supported phospholipid membranes revealed by x-ray and neutron reflection. Soft Matter 8(32), 8294–8297 (2012).
- 70 . Neutron reflectivity studies of the interaction of cubic-phase nanoparticles with phospholipid bilayers of different coverage†. Langmuir 25(7), 4009–4020 (2008).
- 71 Adsorption of cubic liquid crystalline nanoparticles on model membranes. Soft Matter 4(11), 2267–2277 (2008).
- 72 . Cellular uptake and intracellular fate of engineered nanoparticles: a review on the application of imaging techniques. Nanotoxicology 5(3), 381–392 (2011).
- 73 Lipid−quantum dot bilayer vesicles enhance tumor cell uptake and retention in vitro and in vivo. ACS Nano 2(3), 408–418 (2008).
- 74 Translocation of PEGylated quantum dots across rat alveolar epithelial cell monolayers. Int. J. Nanomedicine 6, 2849–2857 (2011).
- 75 Intracellular delivery of a membrane-impermeable enzyme in active form using functionalized gold nanoparticles. J. Am. Chem. Soc. 132(8), 2642–2645 (2010).
- 76 . Non-specific cellular uptake of surface-functionalized quantum dots. Nanotechnology 21(28), 285105 (2010).
- 77 Quantification of nanowire penetration into living cells. Nat. Commun. 5, 3613 (2014).
- 78 . Size-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticles. ACS Nano 3(1), 149–158 (2009).
- 79 . Cell-penetrating HIV1 TAT peptides float on model lipid bilayers. Biochemistry 48(22), 4728–4737 (2009).
- 80 . Cell-penetrating HIV1 TAT peptides can generate pores in model membranes. Biophys. J. 99(1), 153–162 (2010).
- 81 . Probing the influence of the particle in single particle tracking measurements of lipid diffusion. Soft Matter 8(16), 4462–4470 (2012).
- 82 . Multi-resolution 3D visualization of the early stages of cellular uptake of peptide-coated nanoparticles. Nat. Nanotechnol. 9(3), 198–203 (2014).• Presents a newly developed technology that is able to capture the landing process of nanoparticles in real time before cellular uptake in 3D manner.
- 83 . Nanosize and surface charge effects of hydroxyapatite nanoparticles on red blood cell suspensions. ACS Appl. Mater. Interfaces 4(9), 4616–4622 (2012).
- 84 . Interactions of ibuprofen with hybrid lipid bilayers probed by complementary surface-enhanced vibrational spectroscopies. J. Phys. Chem. B 112(45), 14168–14175 (2008).
- 85 . Chemically imaging living cells by scanning electrochemical microscopy. Biosens. Bioelectron. 22(4), 461–472 (2006).
- 86 Investigation of the interactions between silver nanoparticles and HeLa cells by scanning electrochemical microscopy. Analyst 133(9), 1221–1228 (2008).
- 87 . Characterization of Ag+ toxicity on living fibroblast cells by the ferrocenemethanol and oxygen response with the scanning electrochemical microscope. J. Electroanal. Chem. 688, 61–68 (2013).
- 88 . Effect of ZnO nanoparticles on nasopharyngeal cancer cells viability and respiration. Appl. Phys. Lett. 102(11), 113702 (2013).
- 89 Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat. Mater. 7(7), 588–595 (2008).
- 90 . Size-dependent transfection efficiency of PEI-coated gold nanoparticles. Acta Biomater. 7(10), 3645–3655 (2011).
- 91 Effects of serum proteins on intracellular uptake and cytotoxicity of carbon nanoparticles. Carbon 47(5), 1351–1358 (2009).
- 92 . Surface functionalization of nanoparticles to control cell interactions and drug release. Small 8(16), 2585–2594 (2012).
- 93 . Role of target geometry in phagocytosis. Proc. Natl Acad. Sci. USA 103(13), 4930–4934 (2006).
- 94 . Genotoxicity of engineered nanomaterials: a critical review. Nanotoxicology 2(4), 252–273 (2008).
- 95 Quinones and aromatic chemical compounds in particulate matter induce mitochondrial dysfunction: implications for ultrafine particle toxicity. Environ. Health Perspect. 112(14), 1347–1358 (2004).
- 96 . Optical and pharmacological tools to investigate the role of mitochondria during oxidative stress and neurodegeneration. Prog. Neurobiol. 79(3), 136–171 (2006).
- 97 . The pecking order of free radicals and antioxidants: lipid peroxidation, α-tocopherol, and ascorbate. Arch. Biochem. Biophys. 300(2), 535–543 (1993).
- 98 . A suggested mechanism for the production of malonaldehyde during the autoxidation of polyunsaturated fatty acids. Nonenzymatic production of prostaglandin endoperoxides during autoxidation. J. Org. Chem. 40(24), 3615–3617 (1975).
- 99 . Significantly increased levels of serum malonaldehyde in Type 2 diabetics with myocardial infarction. Int. J. Diabetes Dev. Ctries 30(1), 49–51 (2010).
- 100 . Acute ZnO nanoparticles exposure induces developmental toxicity, oxidative stress and DNA damage in embryo–larval zebrafish. Aquat. Toxicol. 136–137, 49–59 (2013).
- 101 . Nanosized copper oxide induces apoptosis through oxidative stress in podocytes. Arch. Toxicol. 87(6), 1067–1073 (2013).
- 102 . Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials 31(23), 5996–6003 (2010).
- 103 . Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan–DNA nanoparticles. Biomaterials 24(7), 1255–1264 (2003).
- 104 . Genotoxic and cytotoxic potential of titanium dioxide (TiO2) nanoparticles on fish cells in vitro. Ecotoxicology 17(5), 410–420 (2008).
- 105 . Estimating the number of viable animal cells in multi-well cultures based on their lactate dehydrogenase activities. Cytotechnology 32(1), 63–75 (2000).
- 106 . A sensitive electrochemical approach for monitoring the effects of nano-Al2O3 on LDH activity by differential pulse voltammetry. Analyst 135(1), 116–120 (2010).
- 107 Toxicity of amorphous silica nanoparticles in mouse keratinocytes. J. Nanopart. Res. 11(1), 15–24 (2009).
- 108 Cytotoxicity and cellular uptake of iron nanowires. Biomaterials 31(7), 1509–1517 (2010).
- 109 . pH-dependent disruption of erythrocyte membrane by amphiphilic poly(amino acid) nanoparticles. J. Biomater. Sci. Polym. Ed. 21(3), 315–328 (2010).
- 110 Antifungal activity and mode of action of silver nano-particles on Candida albicans. Biometals 22(2), 235–242 (2009).
- 111 . Interactions of PEO–PPO–PEO block copolymers with lipid membranes: a computational and experimental study linking membrane lysis with polymer structure. Soft Matter 8(25), 6744–6754 (2012).
- 112 . Biomolecular Simulations – Methods and Protocols. Springer, Germany (2013).
- 113 . Study of the benzocaine transfer from aqueous solution to the interior of a biological membrane. J. Phys. Chem. B 113(29), 9988–9994 (2009).
- 114 . Dynamics of C60 molecules in biological membranes. Computer simulation studies. Bull. Korean Chem. Soc. 31(11), 3195–3200 (2010).
- 115 . A molecular dynamics simulation study of C60 fullerenes inside a dimyristoylphosphatidylcholine lipid bilayer. J. Phys. Chem. B 111(16), 4067–4072 (2007).
- 116 The power of coarse graining in biomolecular simulations. Wiley Interdiscip. Rev. Comput. Mol. Sci. 4(3), 225–248 (2013).
- 117 . Computer simulation study of fullerene translocation through lipid membranes. Nat. Nanotechnol. 3(6), 363–368 (2008).
- 118 Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages. Biomaterials 32(2), 547–555 (2011).
- 119 . Mechanics of receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA 102(27), 9469–9474 (2005).
- 120 . A universal law for cell uptake of one-dimensional nanomaterials. Nano Lett. 14(2), 1049–1055 (2014).
- 121 Single cell 3-D platform to study ligand mobility in cell–cell contact. Lab Chip 11(17), 2876–2883 (2011).
- 122 . Graphene oxide and lipid membranes: interactions and nanocomposite structures. Nano Lett. 12(7), 3356–3362 (2012).
- 123 . Structural rearrangements of polymeric insulin-loaded nanoparticles interacting with surface-supported model lipid membranes. J. Biomater. Nanobiotechnol. 2 (2), 181–193 (2011).
- 124 . Induced dye leakage by PAMAM G6 does not imply dendrimer entry into vesicle lumen. Soft Matter 8(34), 8972–8980 (2012).
- 125 . Facile preparation of cationic gold nanoparticle-bioconjugates for cell penetration and nuclear targeting. ACS Nano 6(9), 7692–7702 (2012).
- 126 . Distribution of functionalized gold nanoparticles between water and lipid bilayers as model cell membranes. Environ. Sci. Technol. 46(3), 1869–1876 (2012).
- 127 . Distribution of fullerene nanomaterials between water and model biological membranes. Langmuir 27(19), 11899–11905 (2011).
- 128 . Electrical method to quantify nanoparticle interaction with lipid bilayers. ACS Nano 7(2), 932–942 (2012).
- 129 Experimental evidence for the interaction of C-60 fullerene with lipid vesicle membranes. Carbon 50(3), 1170–1178 (2012).
- 130 . Mechanistic insight into cell growth, internalization, and cytotoxicity of PAMAM dendrimers. Biomacromolecules 11(2), 382–389 (2009).
- 131 . Freezing or wrapping: the role of particle size in the mechanism of nanoparticle–biomembrane interaction. Langmuir 28(35), 12831–12837 (2012).
- 132 . A simple spectroscopic method for differentiating cellular uptakes of gold nanospheres and nanorods from their mixtures. Angew. Chem. Int. Ed. 49(11), 1976–1980 (2010).
- 133 . A biophysical perspective of understanding nanoparticles at large. Phys. Chem. Chem. Phys. 13(16), 7273–7283 (2011).
- 134 Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes. Int. J. Pharm. 391(1–2), 284–291 (2010).
- 135 . Unraveling dendrimer translocation across cell membrane mimics. Langmuir 28(36), 13025–13033 (2012).